Main Content

Granular Cell Tumor

Granular cell tumor is a tumor showing neuroectodermal differentiation and composed of epithelioid to polygonal cells with copious eosinophilic, distinctively granular cytoplasm.

Symptoms & Causes

Introduction

Granular cell tumor is a neoplasm with neuroectodermal differentiation, characterized by cells with granular cytoplasm, commonly affecting the skin and mucosal surfaces.

Reference
WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2024 09 11]. (WHO classification of tumours series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/chapters/33.

Related Terminology
Not recommended: granular cell schwannoma; granular cell nerve sheath tumor; granular cell myoblastoma; Abrikossoff tumor.

Subtype(s)
Granular cell tumor, malignant

Symptoms

Although usually asymptomatic, granular cell tumor can be pruritic to painful in the skin and tongue. Cutaneous lesions are firm, flesh-colored to reddish-brown, and 0.5–3.0 cm in size. Tumor growth is usually indolent.

Localization

Most cases affect deep dermis and subcutaneous tissue, particularly of the head and neck, trunk, and proximal extremities. The single most common site is the tongue, representing 25% of cases, followed by breast (5–15%). Visceral involvement of the gastrointestinal tract (esophagus, large bowel, perianal area) and respiratory tract (larynx) is also common. Although most granular cell tumors are solitary, as many as 10% are multifocal, and these can be regional or involve multiple organ sites. Most bona fide malignant granular cell tumors occur in the deep soft tissue, with a predilection for the trunk and extremities, the thigh being the single most common site. Head and neck and oral locations are less common for malignant tumors.

Epidemiology

Granular cell tumors usually occur in adults in the fourth to sixth decades of life, but they can be encountered at any age. They are more prevalent in males than females (M:F ratio: 2–3:1), as well as in African-Americans, in whom multiple lesions are also more common. Malignant granular cell tumor is very rare and occurs with a female predominance and an age range of 3–70 years (mean: 40 years).

Etiology

Multiple granular cell tumors have been reported in association with various syndromes, such as neurofibromatosis type 1, Noonan syndrome, and LEOPARD syndrome (multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormal genitalia, retardation of growth, and sensorineural deafness), mostly characterized by aberrant signaling within the RAS/MAPK pathway through inactivating mutations.

Diagnosis & Treatment

Staging

Malignant granular cell tumor of somatic soft tissue can be staged according to the American Joint Committee on Cancer (AJCC) eighth-edition TNM staging system for soft tissue sarcoma of the trunk and extremities, although given the rarity of this entity, there is not current evidence demonstrating prognostic power for this approach.

Pathogenesis

Loss-of-function mutations affecting the V-ATPase accessory genes, ATP6AP1 (61%) and ATP6AP2 (11%), are found in 72% of granular cell tumors collectively. These genes play pivotal roles in endosomal pH regulation; loss-of-function mutations affecting these genes are found irrespective of anatomical site or whether the lesions are benign or malignant, and they have not been detected in other neoplasms. Therefore, loss-of-function ATP6AP1 or ATP6AP2 mutations appear to be pathognomonic for the diagnosis of granular cell tumor. Granular cell tumors lacking mutations in these genes have been reported to harbor mutations affecting other V-ATPase-related genes. Inactivation of either ATP6AP1 or ATP6AP2 in Schwann cells leads to the accumulation of intracytoplasmic granules that are characteristic of granular cell tumor. Analysis of the granules revealed that they display ultrastructural and immunophenotypic features of early and recycling endosomes. The mechanism by which loss-of-function mutations in endosomal regulatory proteins drive oncogenesis is currently unknown.

Macroscopic Appearance

Granular cell tumors are uninodular, firm masses involving the skin/subcutis or submucosa, often with an overlying epithelial hyperplasia. On sectioning, the tumor has a yellowish, finely granular texture. Malignant granular cell tumors range in size from 1 to 18.2 cm, usually being > 5 cm. Grossly, tumors are pale grey and firm, often deeper (subcutaneous/intramuscular) than their benign counterparts.

Histopathology

Granular cell tumor has ill-defined borders and is composed of sheets, nests, and trabeculae of large, monotonous epithelioid to polygonal cells with intensely eosinophilic, granular cytoplasm. Cell borders may be indistinct, producing a syncytial appearance. Nuclei are usually centrally situated and range from uniformly small and mildly hyperchromatic to larger and vesicular with distinct nucleoli. Mitoses are variable in number but usually not prominent.

The finely granular appearance of the cytoplasm is due to massive accumulation of lysosomes including larger intracytoplasmic granules highlighted by clear halos. Perineural infiltration is common. For cutaneous granular cell tumor and granular cell tumor arising in sites such as the tongue and esophagus with overlying squamous epithelium, pseudoepitheliomatous hyperplasia is sometimes seen and when extensive can raise the consideration of squamous cell carcinoma.

Malignant granular cell tumors are rare and their features vary from overtly sarcomatous to morphologically bland on rare occasions. Histological features associated with malignancy include increased cellularity, prominent spindling, high N:C ratio, vesicular nuclei with prominent nucleoli, marked pleomorphism, increased mitotic activity (> 2 mitoses per 2 mm²), and geographical necrosis. Although most malignant granular cell tumors show necrosis and/or high mitotic activity, these parameters alone may not identify all tumors that metastasize.

Granular cell tumors are generally reactive for S100, SOX10, nestin, inhibin, and calretinin. Tumors are also positive for CD68, CD63 (NKI/C3), and NSE, probably nonspecific due to the cytoplasmic lysosomal content. MITF and TFE3 (in the absence of gene rearrangements) show diffuse nuclear reactivity in most cases, but HMB45 is uniformly negative and only very rarely is there focal reactivity for melan-A.

Cytology

In FNA samples, the characteristic granular cytoplasm and bland nuclei are useful features, but carcinomas (particularly apocrine) and histiocytic processes must be considered.

Prognosis and Prediction

Although granular cell tumor is benign in the vast majority of cases, local recurrence can sometimes be seen after incomplete excision. Malignant granular cell tumor has a 50% rate of metastasis. Local recurrence, metastasis, larger tumor size, and older patient age are adverse prognostic factors for malignant granular cell tumor.

Clinical Features

Diagnostic Molecular Pathology

Not clinically relevant

Essential and Desirable Diagnostic Criteria

Essential: nests and sheets of epithelioid to polygonal cells; abundant, intensely eosinophilic, granular cytoplasm; positive for S100 and SOX10 by immunohistochemistry.

ribbon

Make a Donation

Help us move closer to a world where people do not die from sarcoma

Make a Donation
ribbon

section